Private Equity

Updated:

Chuangjian Capital

Chuangjian Capital is a private equity based in Beijing, founded 2014; the Altss profile covers its classification, headquarters, registration, AUM band, and...

Chuangjian Capital

Chuangjian Capital is a private equity firm based in Beijing, China. It focuses on venture capital investments.

General information

Firm type

Private Equity

Year founded

2014

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Sector focus

Enterprise SoftwareAI/MLDigital HealthMobility & TransportationRobotics & Automation

Frequently asked questions

Who runs investment decisions at Chuangjian Capital?

Zhu Xiaohu is the sole general partner and final decision-maker on every investment. He chairs the investment committee and personally signs off on each allocation, a governance model that gives the firm its characteristic speed — term sheets often reach founders within 72 hours of the first meeting. There is no distributed partnership vote; the team sources and screens, but Zhu makes the call.

How does Chuangjian source its deal flow?

Chuangjian built a proprietary data platform that tracks startup formation signals — talent movements from top-tier tech companies, academic paper registrations, GitHub repository activity, and product launch timelines — to surface companies before they formally fundraise. The firm supplements this with on-campus relationships at Tsinghua, Peking University, and Zhejiang University, where many of its earliest portfolio founders originated. This dual human-and-machine approach allows Chuangjian to meet founders before they have engaged other venture investors.

Does Chuangjian invest via fund commitments or only direct deals?

Chuangjian invests exclusively through direct equity deals in operating companies, writing seed, pre-A, and Series A checks. It does not commit capital as a limited partner to other venture funds, nor does it participate in fund-of-funds structures. The firm's model is pure direct investing, with the majority of capital reserved for follow-on rounds in its own portfolio companies.

What investment stages does Chuangjian target?

The sweet spot is seed and pre-A, where Chuangjian writes initial checks of $500,000 to $3 million. After that, the firm reserves roughly two-thirds of each fund's capital for follow-on rounds — often preempting formal Series A processes by approaching founders directly with term sheets the moment key milestones are hit. It will occasionally enter at Series A for companies it missed at seed, but only when it can lead or co-lead the round.

Is Chuangjian's capital RMB-denominated or USD-denominated?

Chuangjian operates parallel RMB and USD fund structures, which allows it to invest across both domestic Chinese startups and Chinese-founded teams incorporating in offshore jurisdictions like the Cayman Islands. Its seventh USD fund closed at $420 million in early 2024, with commitments from university endowments and sovereign wealth funds. The RMB vehicles draw from Chinese institutional limited partners and are structured to accommodate onshore exits via the STAR Market and ChiNext.

What is Chuangjian's known posture on co-investments alongside external GPs?

Chuangjian typically leads or co-leads its rounds and does not frequently syndicate minority positions alongside competing venture firms in initial investments. The firm prefers to set terms and control allocation, bringing in co-investors selectively when additional sector expertise or international expansion capital is needed. On follow-on rounds, it is known to exercise pro-rata rights aggressively and has occasionally preempted other investors by offering founders a bridge round before a formal fundraise launches.

Which sectors does Chuangjian explicitly avoid?

Chuangjian has publicly stated it does not invest in consumer internet marketplaces, social media platforms, or content businesses — categories it views as mature and capital-inefficient for early-stage venture. It also avoids real estate technology and traditional manufacturing. The firm maintains a hard filter against any business model dependent on regulatory arbitrage in financial services or healthcare.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Beijing Private Equity profiles